A previous study showed that the circulating CTLA-4 levels and the CTLA4 rs231775 polymorphism are associated with the condition and progression of chronic liver disease caused by HBV and HCC, and thus, their determination may be used for prognosis and monitoring disease progression [28]. Here, CTLA4 is linked to hepatocellular carcinoma.